Progressive pulmonary sarcoidosis - A fibroproliferative process potentially triggered by EGR-1 and IL-6

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 23, Issue 1, 2006, Pages 38-50

  Bihl, Michel P ^a   Laule Kilian, Kirsten ^a   Bubendorf, Lukas ^a   Rutherford, Robert M ^b   Baty, Florent ^a   Kehren, Jeanne ^c   Eryüksel, Emel ^a   Staedtler, Frank ^c   Yang, Jing Qing ^a   Goulet, Stephanie ^a   Gilmartin, John J ^b   Tamm, Michael ^a   Brutsche, Martin H ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL GALWAY   (Ireland)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Gene chip; Growth factors; Lung fibroblasts

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CYCLOHEXIMIDE; DACTINOMYCIN; DEXAMETHASONE; EARLY GROWTH RESPONSE FACTOR 1; GROWTH FACTOR; INTERLEUKIN 6;

ANGIOGENESIS; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; FIBROSIS; GENE EXPRESSION; GRANULOMATOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LUNG BIOPSY; LUNG FIBROBLAST; LUNG FIBROSIS; MESENCHYME; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARCOIDOSIS; UPREGULATION;

CASE-CONTROL STUDIES; CELL DIVISION; CELL LINE; EARLY GROWTH RESPONSE PROTEIN 1; FIBROBLASTS; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; OLIGONUCLEOTIDES, ANTISENSE; PLATELET-DERIVED GROWTH FACTOR; SARCOIDOSIS, PULMONARY;

EID: 33747496382     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Hunninghake GW, Costabel U, Ando M, et al: ATS/ERS/WASOG Statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders Sarcoidosis Vasc Diffuse Lung Dis 1999; 16: 149-73.
2. Baughman RP, Lower EE, Du Bois RM: Sarcoidosis. Lancet 2003; 361: 1111-8.
3. Grutters JC, Sato H, Pantelidis P, et al: Increased frequency of the uncommon tumor necrosis factor -857T allele in British and Dutch patients with sarcoidosis. Am J Respir Crit Care Med 2002; 165: 1119-24.
4. Hutyrova B, Pantelidis P, Drabek J, et al: Interleukin-1 gene cluster polymorphisms in sarcoidosis and idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2002; 165: 148-51.
5. Takada T, Suzuki E, Morohashi K, Gejyo F: Association of single nucleotide polymorphisms in the IL-18 gene with sarcoidosis in a Japanese population. Tissue Antigens 2002; 60: 36-42.
6. Zorzetto M, Bombieri C, Ferrarotti I, et al: Complement receptor 1 gene polymorphisms in sarcoidosis. Am J Respir Cell Mol Biol 2002; 27: 17-23.
7. Hattori N, Niimi T, Sato S, et al: Cytotoxic T-lymphocyte antigen 4 gene polymorphisms in sarcoidosis patients. Sarcoidosis Vasc Diffuse Lung Dis 2005; 22: 27-32.
8. Grutters JC, Sato H, Pantelidis P, et al: Analysis of IL6 and IL1A gene polymorphisms in UK and Dutch patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2003; 20: 20-7.
9. Murakozy G, Gaede KJ, Zissel G, Schlaak M, Muller-Quernheim J: Analysis of gene polymorphisms in interleukin-10 and transforming growth factor-beta 1 in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2001; 18: 165-9.
10. Kunkel SL, Chensue SW, Strieter RM, Lynch JP, Remick DG: Cellular and molecular aspects of granulomatous inflammation. Am J Respir Cell Mol Biol 1989; 1: 439-47.
11. Atamas SP: Complex cytokine regulation of tissue fibrosis. Life Sci 2002; 72: 631-43.
12. Meyer KC, Kaminski MJ, Calhoun WJ, Auerbach R: Studies of bronchoalveolar lavage cells and fluids in pulmonary sarcoidosis. I. Enhanced capacity of bronchoalveolar lavage cells from patients with pulmonary sarcoidosis to induce angiogenesis in vivo. Am Rev Respir Dis 1989; 140: 1446-9.
13. Turner-Warwick M: Precapillary Systemic-Pulmonary Anastomoses. Thorax 1963; 18: 225-37.
14. Peao MN, Aguas AP, de Sa CM, Grande NR: Neoformation of blood vessels in association with rat lung fibrosis induced by bleomycin. Anat Rec 1994; 238: 57-67.
15. Abo-Auda W, Benza RL: Therapeutic angiogenesis: review of current concepts and future directions. J Heart Lung Transplant 2003; 22: 370-82.
16. Bernard A, Marchandise FX, Depelchin S, Lauwerys R, Sibille Y: Clara cell protein in serum and bronchoalveolar lavage. Eur Respir J 1992; 5: 1231-8.
17. Chinet T, Dusser D, Labrune S, et al: Lung function declines in patients with pulmonary sarcoidosis and increased respiratory epithelial permeability to 99mTc-DTPA. Am Rev Respir Dis 1990; 141: 445-9.
18. Hermans C, Petrek M, Kolek V, et al: Serum Clara cell protein (CC16), a marker of the integrity of the air-blood barrier in sarcoidosis. Eur Respir J 2001; 18: 507-14.
19. Tamura R, Sato A, Chida K, Suganuma H: Fibroblasts as target and effector cells in Japanese patients with sarcoidosis. Lung 1998; 176: 75-87.
20. Rutherford RM, Kehren J, Staedtler F, et al: Functional genomics in sarcoidosis-reduced or increased apoptosis? Swiss Med Wkly 2001; 131: 459-70.
21. Rutherford RM, Staedtler F, Kehren J, et al: Functional genomics and prognosis in sarcoidosis - the critical role of antigen presentation. Sarcoidosis Vasc Diffuse Lung Dis 2004; 21: 10-18.
22. R Development Core Team.
23. Huber W, von Heydebreck A, Sultmann H, Poustka A, Vingron M: Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 2002; 18 (suppl. 1): S96-104.
24. Culhane AC, Perriere G, Considine EC, Cotter TG, Higgins DG: Between-group analysis of microarray data. Bioinformatics 2002; 18: 1600-8.
25. Chessel D, Dufour AB, Thioulouse J: The ade4 package - I: One-table methods. R News 2004; 4: 5-10.
26. Fellenberg K, Hauser NC, Brors B, et al: Correspondence analysis applied to microarray data. Proc Natl Acad Sci USA 2001; 98: 10781-6.
27. Benjamini Y, Hochberg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. JR Statist Soc B 1995; 57: 289-300.
28. Hagiwara K, Stenman G, Honda H, et al: Organization and chromosomal localization of the human platelet-derived endothelial cell growth factor gene. Mol Cell Biol 1991; 11: 2125-32.
29. Muller-Quernheim J, Pfeifer S, Mannel D, Strausz J, Ferlinz R: Lung-restricted activation of the alveolar macrophage/monocyte system in pulmonary sarcoidosis. Am Rev Respir Dis 1992; 145: 187-92.
30. Su M, West CA, Young AJ, et al: Dynamic deformation of migratory efferent lymph-derived cells "trapped" in the inflammatory microcirculation. J Cell Physiol 2003; 194: 54-62.
31. Aicher WK, Sakamoto KM, Hack A, Eibel H: Analysis of functional elements in the human Egr-1 gene promoter. Rheumatol Int 1999; 18: 207-14.
32. Lee CG, Cho SJ, Kang MJ, et al: Early Growth Response Gene 1-mediated Apoptosis Is Essential for Transforming Growth Factor {beta}1-induced Pulmonary Fibrosis. J Exp Med 2004; 200: 377-89.
33. Paramothayan S, Jones PW: Corticosteroid therapy in pulmonary sarcoidosis: a systematic review. JAMA 2002; 287: 1301-7.
34. Matsuo T, Itami M, Shiraga F: Choroidopathy in patients with sarcoidosis observed by simultaneous indocyanine green and fluorescein angiography. Retina 2000; 20: 16-21.
35. Mikami R, Sekiguchi M, Ryuzin Y, et al: Changes in the peripheral vasculature of various organs in patients with sarcoidosis - possible role of microangiopathy. Heart Vessels 1986; 2: 129-39.
36. Morohashi K, Takada T, Omori K, Suzuki E, Gejyo F: Vascular endothelial growth factor gene polymorphisms in Japanese patients with sarcoidosis. Chest 2003; 123: 1520-6.
37. Liu C, Adamson E, Mercola D: Transcription factor EGR-1 suppresses the growth and transformation of human HT-1080 fibrosarcoma cells by induction of transforming growth factor beta 1. Proc Natl Acad Sci USA 1996; 93: 11831-6.
38. Liu C, Yao J, de Belle I, et al: The transcription factor EGR-1 suppresses transformation of human fibrosarcoma HTE1080 cells by coordinated induction of transforming growth factor-beta1, fibronectin, and plasminogen activator inhibitor-1. J Biol Chem 1999; 274: 4400-11.
39. Kim KK, Flaherty KR, Long Q, et al: A plasminogen activator inhibitor-1 promoter polymorphism and idiopathic interstitial pneumonia. Mol Med 2003; 9: 52-6.
40. Eickelberg O, Pansky A, Koehler E, et al: Molecular mechanisms of TGF-(beta) antagonism by interferon (gamma) and cyclosporine A in lung fibroblasts. FASEB J 2001; 15: 797-806.